Imatinib is such a drug that inhibits oncogenic tyrosine kinases c-Abl and c-kit used in the treatment of chronic leukemias and gastrointestinal stromal tumors respectively5,6. Here, ABL1 is linked to gastrointestinal stromal tumor.